Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, Diagnosis, and Evidence-Based Treatments Genitourinary Syndrome of Menopause (GSM)—formerly referred to as vulvovaginal atrophy—is a chronic, progressive medical condition that affects millions of women during and after the menopausal transition. While public awareness of menopausal vasomotor symptoms (such as hot flushes and night sweats) has grown significantly, GSM...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Diagnosis, and Evidence-Based Treatments Genitourinary Syndrome of Menopause (GSM)—formerly referred to as vulvovaginal atrophy (VVA)—is a chronic, progressive condition affecting between 50% and 70% of postmenopausal women. The term was introduced in 2014 by The International Society for the Study of Women's Sexual Health (ISSWSH) and The Menopause Society (formerly NAMS) to...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research for How do clinicians manage transient micro-wheals or papules following skin booster placement in ultra-thin atrophic vaginal walls?.

Understanding Genitourinary Syndrome of Menopause (GSM): Causes, Symptoms, Diagnosis, and Advanced Regenerative Treatments For generations, women transitioning through perimenopause and menopause have been told that intimate dryness, irritation, and painful intercourse are merely inevitable, untreatable markers of getting older. Many suffer in silence due to embarrassment or a lack of awareness regarding available clinical solutions. However,...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research for How does the altered thermal relaxation time of thin, dry vaginal walls affect pulse duration selection in Erbium:YAG treatments?.

Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research for How do clinicians objectively assess sub-mucosal tissue density and neocollagenesis timelines between regenerative injectable sessions in oestrogen-starved patients?.

Understanding Localised Haematomas: Microvascular Causes, Symptoms, and Evidence-Based Management A localised haematoma is an extravascular collection of blood that forms when an arterial, venous, or capillary wall is injured, allowing blood to escape and accumulate within surrounding soft tissue planes or body cavities. In clinical practice, purpura describes purplish cutaneous or mucosal lesions resulting from tissue hemorrhage. Lesions...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Restoring Pelvic Floor Integrity: Understanding Pelvic Floor Dysfunction and the Promise of Exosome Therapy Pelvic floor dysfunction (PFD)—a term encompassing conditions such as pelvic organ prolapse (POP), stress urinary incontinence (SUI), and genitourinary syndrome of menopause (GSM) / vaginal atrophy—represents a major global health concern affecting approximately 40% of women over their lifetime. Despite its high prevalence, many women...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): Symptoms, Causes, and Modern Treatment Options Genitourinary Syndrome of Menopause (GSM)—historically referred to as vulvovaginal atrophy (VVA) or atrophic vaginitis—is a progressive, chronic condition affecting the vulva, vagina, urethra, and bladder. While vasomotor symptoms like hot flashes often lessen over time, GSM symptoms typically persist or worsen without targeted management. ---...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.

Understanding Genitourinary Syndrome of Menopause (GSM): A Comprehensive Clinical Guide to Symptoms, Causes, and Modern Treatments Genitourinary Syndrome of Menopause (GSM) is a chronic, progressive condition that affects up to 50% to 70% of postmenopausal women, as well as approximately 15% of premenopausal women experiencing hypoestrogenic states. Formally introduced in 2014 by the International Society for the Study of Women’s Sexual Health...Read the full clinical guide: https://thewomenshealthclinic.co.uk/faqs/This clinical audio overview covers the latest standards in patient care and research.